Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Tandem mass spectrometry screening and genetic analysis of neonates with Urea cycle disorders]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 39779333 | PubTator, text mining | PubMed |
| Advances in the impact of ASS1 dysregulation on metabolic reprogramming of tumor cells. | Cell Signal | 2025 | 39778698 | PubTator, text mining | PubMed |
| Rbfox3 Promotes Transformation of MDSC-Like Tumor Cells to Shape Immunosuppressive Microenvironment. | Adv Sci (Weinh) | 2025 | 39777898 | PubTator, text mining | PubMed |
| Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma. | iScience | 2025 | 39758821 | PubTator, text mining | PubMed |
| Emerging biotechnologies for engineering liver organoids. | Bioact Mater | 2025 | 39588483 | PubTator, text mining | PubMed |
| The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS1. | Mol Carcinog | 2025 | 39513657 | PubTator, text mining | PubMed |
| Spatial and Single-Cell Transcriptomics Reveals the Regional Division of the Spatial Structure of MASH Fibrosis. | Liver Int | 2025 | 39400982 | PubTator, text mining | PubMed |
| ASS1 enhances anoikis resistance via AMPK/CPT1A-mediated fatty acid metabolism in ovarian cancer. | Cancer Lett | 2025 | 38914306 | PubTator, text mining | PubMed |
| Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia. | Curr Pharmacol Rep | 2024 | 40756330 | PubTator, text mining | PubMed |
| Serum proteomic and metabolomic profiling of hepatocellular carcinoma patients co-infected with Clonorchis sinensis. | Front Immunol | 2024 | 39840062 | PubTator, text mining | PubMed |
| Short-term probiotic supplementation affects the diversity, genetics, growth, and interactions of the native gut microbiome. | Imeta | 2024 | 39742297 | PubTator, text mining | PubMed |
| Visualization of argininosuccinate synthetase by in silico analysis: novel insights into citrullinemia type I disorders. | Front Mol Biosci | 2024 | 39649700 | PubTator, text mining | PubMed |
| Endothelial cell Ass1 inhibits arteriosclerotic calcification in diabetes mellitus. | Biomed Pharmacother | 2024 | 39642445 | PubTator, text mining | PubMed |
| PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer. | Cancer Res Commun | 2024 | 39570001 | PubTator, text mining | PubMed |
| Role of Arginine and its Metabolism in TGF-β-Induced Activation of Lung Fibroblasts. | bioRxiv | 2024 | 39554075 | PubTator, text mining | PubMed |
| Met-Flow analyses of the metabolic heterogeneity associated with different stages of cord blood-derived hematopoietic cell differentiation. | Front Immunol | 2024 | 39483465 | PubTator, text mining | PubMed |
| The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial). | Trials | 2024 | 39415282 | PubTator, text mining | PubMed |
| Editorial: Gateways to the brain: vascular-glial-immune network in health and disease. | Front Cell Neurosci | 2024 | 39391762 | PubTator, text mining | PubMed |
| Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature. | Front Pharmacol | 2024 | 39239650 | PubTator, text mining | PubMed |
| Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis. | J Virol | 2024 | 39194244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=8